Útdráttur
Background: Hereditary deficiency of adenine phosphoribosyltransferase causes 2,8-dihydroxyadenine (2,8-DHA) nephropathy, a rare condition characterized by formation of 2,8-DHA crystals within renal tubules. Clinical relevance of rodentmodels of 2,8-DHAcrystal nephropathy induced by excessive adenine intake is unknown. Methods: Using animal models and patient kidney biopsies, we assessed the pathogenic sequelae of 2,8- DHA crystal-induced kidney damage. We also used knockout mice to investigate the role of TNF receptors 1 and 2 (TNFR1 and TNFR2), CD44, or alpha2-HS glycoprotein (AHSG), all of which are involved in the pathogenesis of other types of crystal-induced nephropathies. Results: Adenine-enriched diet in mice induced 2,8-DHA nephropathy, leading to progressive kidney disease, characterized by crystal deposits, tubular injury, inflammation, and fibrosis. Kidney injury depended on crystal size. The smallest crystals were endocytosed by tubular epithelial cells. Crystals of variable size were excreted in urine. Large crystals obstructed whole tubules. Medium-sized crystals induced a particular reparative process that we term extratubulation. In this process, tubular cells, in coordination with macrophages, overgrew and translocated crystals into the interstitium, restoring the tubular luminal patency; this was followed by degradation of interstitial crystals by granulomatous inflammation. Patients with adenine phosphoribosyltransferase deficiency showed similar histopathological findings regarding crystal morphology, crystal clearance, and renal injury. In mice, deletion of Tnfr1 significantly reduced tubular CD44 and annexin two expression, as well as inflammation, thereby ameliorating the disease course. In contrast, genetic deletion of Tnfr2, Cd44, or Ahsg had no effect on the manifestations of 2,8- DHA nephropathy. Conclusions: Rodentmodels of the cellular andmolecular mechanisms of 2,8-DHA nephropathy and crystal clearance have clinical relevance and offer insight into potential future targets for therapeutic interventions.
| Upprunalegt tungumál | Enska |
|---|---|
| Síður (frá-til) | 799-816 |
| Síðufjöldi | 18 |
| Fræðitímarit | Journal of the American Society of Nephrology |
| Bindi | 31 |
| Númer tölublaðs | 4 |
| DOI | |
| Útgáfustaða | Útgefið - apr. 2020 |
Athugasemd
Funding Information: This study was financially supported by the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG): SFB/TRR57, SFB/TRR219, BO3755/3-1, BO3755/6-1, AN372/16-2, and 24-1), the German Federal Ministry of Education and Research (Bundesministerium f?r Bildung und Forschung (BMBF): STOP-FSGS-01GM1901A), the RWTH Interdisciplinary Centre for Clinical Research (Interdisziplin?res Zentrum f?r Klinische Forschung (IZKF): O3-2), and the Medical Faculty of the RWTH Aachen University (START 09/15). Dr. Edvardsson and Dr. Palsson are supported by the Rare Kidney Stone Consortium (U54DK083908), a part of the National Center for Advancing Translational Sciences (NCATS) Rare Diseases Clinical Research Network. The Rare Kidney Stone Consortium is funded through collaboration between NCATS and the National Institute of Diabetes and Digestive and Kidney Diseases. Funding Information: This study was financially supported by the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG): SFB/TRR57, SFB/TRR219, BO3755/3-1, BO3755/6-1, AN372/16-2, and 24-1), the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung (BMBF): STOP-FSGS-01GM1901A), the RWTH Interdisciplinary Centre for Clinical Research (Interdisziplinäres Zentrum für Klinische For-schung (IZKF): O3-2), and the Medical Faculty of the RWTH Aachen University (START 09/15). Dr. Edvardsson and Dr. Palsson are supported by the Rare Kidney Stone Consortium (U54DK083908), a part of the National Center for Advancing Translational Sciences (NCATS) Rare Diseases Clinical Research Network. The Rare Kidney Stone Consortium is funded through collaboration between NCATS and the National Institute of Diabetes and Digestive and Kidney Diseases. Publisher Copyright: Copyright © 2020 by the American Society of Nephrology.SÞ SDG
Þessi afurð stuðlar að eftirfarandi markmiðum um sjálfbæra þróun
-
SDG Heilsa og vellíðan
Fingerprint
Sökktu þér í rannsóknarefni „Cellular and molecular mechanisms of kidney injury in 2,8-dihydroxyadenine nephropathy“. Saman myndar þetta einstakt fingrafar.Vitna í þetta
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver